You searched for "AMD"
Post hoc analysis of the CANTREAT randomised trial
1 December 2023
| Sofia Rokerya
|
EYE - Vitreo-Retinal
|
Age-related macular degeneration, Randomized clinical trial, Ranibizumab, Treat-and-extend
CANTREAT, a Canadian multicentre two-year randomised trial compares treat and extend treatment (T&E) relative to the monthly administration of Ranibizumab in nAMD. Two-hundred and eighty-five treatment-naïve patients with nAMD were randomised to receive either a once-monthly dosing or T&E regimen...
New survey reveals over half of UK adults expect to experience sight loss in the next 10 years.
This survey and media article are fully organised and funded by Apellis. New survey reveals over half of UK adults expect to experience sight loss in the next 10 years. Yet more than one in four (29%) of those surveyed...CHEC Wandsworth welcomes Marsha de Cordova MP to discuss her National Eye Health Strategy Bill
CHEC, a community healthcare provider delivering specialist ophthalmology services in partnership with the NHS, recently welcomed Marsha de Cordova, Labour MP for Battersea, to its new site in Wandsworth (Friday 17th Jan 2025) to share insights on how independent eyecare...
RPE tears after intravitreal Lucentis
1 February 2017
| Saruban Pasu
|
EYE - Vitreo-Retinal
The current hypothesis regarding retinal pigment epithelium (RPE) tears is the contraction and fibrosis in choroidal neovascularisation (CNV) tissue after anti-VEGF therapy can induce rips in the overlying RPE. This South Korean study aimed to identify the association between RPE...
What's trending Apr/May 2022
5 April 2022
| Stephanie Chiu
|
EYE - General
A round-up of the eye-related hot topics that have been trending over the last few weeks. #ArgusI #ArgusII #bioniceye #retinitispigmentosa #SecondSight Remember Argus I & Argus II? Its star burned bright, touted as the future of treatment for retinitis pigmentosa....
The challenges of rural optometry and how independent prescribing has helped
1 February 2017
| Ian Rough
|
EYE - General
Why move from a busy professional independent Aberdeen optometry practice over 200 miles to one of the most remote places in the United Kingdom? I could talk about the professional challenge of supporting a rural community, or the chance to...
Preview: Oxford Ophthalmological Congress
18 June 2024
| Samuel Verdin
|
conferences, events, Oxford, OOC, registration, opportunities, education, meeting, England, UK
Between 1–3 July, we will be heading down to England for the 107th Oxford Ophthalmological Congress.
Learnings and trends in the management of open-angle and angle-closure glaucoma
1 August 2017
| Winifred Nolan, Nick Strouthidis, Keith Barton
|
EYE - Glaucoma
To be truly disruptive, newer technologies need to offer a quality of life benefit over medication to a broad population of glaucoma sufferers. Evidence and converging trends in medical and surgical management of glaucoma were explored in counterpoint discussions and...
The extended role of the specialist ophthalmic photographer
The prevalence of certain retinal conditions such as diabetic retinopathy and age-related macular degeneration (ARMD) is projected to grow substantially over the next decades. Estimates for the projected growth in burden on eye services for diabetic retinopathy and neovascular ARMD...Sight Scotland and Sight Scotland Veterans appoint Paul Bott as new Chair of the Board
Sight Scotland and Sight Scotland Veterans are delighted to announce the appointment of Paul Bott as the new Chair of the Board.Hertfordshire and West Essex ICB accredits CHEC as a system provider of gastroenterology services
CHEC Stevenage, a community-based hospital, aims to increase patient choice and maintain short waiting times.RCOphth 2024 Preview
17 May 2024
| Samuel Verdin
Here is our annual highlights preview of the upcoming RCOphth 2024 Annual Congress in Belfast's ICC, 20-23 May.
